These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36923539)

  • 1. Proteomes from AMPK-inhibited peripheral blood mononuclear cells suppress the progression of breast cancer and bone metastasis.
    Li K; Sun X; Minami K; Tamari K; Ogawa K; Li H; Ma H; Zhou M; Na S; Li BY; Yokota H
    Theranostics; 2023; 13(4):1247-1263. PubMed ID: 36923539
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling.
    Sun X; Li K; Hase M; Zha R; Feng Y; Li BY; Yokota H
    Theranostics; 2022; 12(2):929-943. PubMed ID: 34976221
    [No Abstract]   [Full Text] [Related]  

  • 3. Counterintuitive production of tumor-suppressive secretomes from Oct4- and c-Myc-overexpressing tumor cells and MSCs.
    Li K; Sun X; Zha R; Liu S; Feng Y; Sano T; Aryal UK; Sudo A; Li BY; Yokota H
    Theranostics; 2022; 12(7):3084-3103. PubMed ID: 35547745
    [No Abstract]   [Full Text] [Related]  

  • 4. Generation of the tumor-suppressive secretome from tumor cells.
    Liu S; Sun X; Li K; Zha R; Feng Y; Sano T; Dong C; Liu Y; Aryal UK; Sudo A; Li BY; Yokota H
    Theranostics; 2021; 11(17):8517-8534. PubMed ID: 34373756
    [No Abstract]   [Full Text] [Related]  

  • 5. Preventing tumor progression to the bone by induced tumor-suppressing MSCs.
    Sun X; Li K; Zha R; Liu S; Fan Y; Wu D; Hase M; Aryal UK; Lin CC; Li BY; Yokota H
    Theranostics; 2021; 11(11):5143-5159. PubMed ID: 33859739
    [No Abstract]   [Full Text] [Related]  

  • 6. The inhibition of pancreatic cancer progression by K-Ras-overexpressing mesenchymal stem cell-derived secretomes.
    Huo Q; Li K; Sun X; Zhuang A; Minami K; Tamari K; Ogawa K; Fishel ML; Li BY; Yokota H
    Sci Rep; 2023 Sep; 13(1):15036. PubMed ID: 37699930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-enolase promotes tumorigenesis and metastasis via regulating AMPK/mTOR pathway in colorectal cancer.
    Zhan P; Zhao S; Yan H; Yin C; Xiao Y; Wang Y; Ni R; Chen W; Wei G; Zhang P
    Mol Carcinog; 2017 May; 56(5):1427-1437. PubMed ID: 27996156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of osteosarcoma progression by engineered lymphocyte-derived proteomes.
    Li K; Sun X; Li H; Ma H; Zhou M; Minami K; Tamari K; Ogawa K; Pandya PH; Saadatzadeh MR; Kacena MA; Pollok KE; Li BY; Yokota H
    Genes Dis; 2023 Jul; 10(4):1641-1656. PubMed ID: 37397541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMPK inhibits MTDH expression via GSK3β and SIRT1 activation: potential role in triple negative breast cancer cell proliferation.
    Gollavilli PN; Kanugula AK; Koyyada R; Karnewar S; Neeli PK; Kotamraju S
    FEBS J; 2015 Oct; 282(20):3971-85. PubMed ID: 26236947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion of Osteoclasts into Bone-Protective, Tumor-Suppressing Cells.
    Li KX; Sun X; Li BY; Yokota H
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditioned media of pancreatic cancer cells and pancreatic stellate cells induce myeloid-derived suppressor cells differentiation and lymphocytes suppression.
    Chong YP; Peter EP; Lee FJM; Chan CM; Chai S; Ling LPC; Tan EL; Ng SH; Masamune A; Ghafar SAA; Ismail N; Ho KL
    Sci Rep; 2022 Jul; 12(1):12315. PubMed ID: 35853996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy Facilitates Metadherin-Induced Chemotherapy Resistance Through the AMPK/ATG5 Pathway in Gastric Cancer.
    Pei G; Luo M; Ni X; Wu J; Wang S; Ma Y; Yu J
    Cell Physiol Biochem; 2018; 46(2):847-859. PubMed ID: 29635244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
    Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
    Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gold clusters prevent breast cancer bone metastasis by suppressing tumor-induced osteoclastogenesis.
    Zhang Z; Yao Y; Yuan Q; Lu C; Zhang X; Yuan J; Hou K; Zhang C; Du Z; Gao X; Chen X
    Theranostics; 2020; 10(9):4042-4055. PubMed ID: 32226538
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological Inhibition of the Skeletal IKKβ Reduces Breast Cancer-Induced Osteolysis.
    Marino S; Bishop RT; Mollat P; Idris AI
    Calcif Tissue Int; 2018 Aug; 103(2):206-216. PubMed ID: 29455416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells promote colorectal cancer progression through AMPK/mTOR-mediated NF-κB activation.
    Wu XB; Liu Y; Wang GH; Xu X; Cai Y; Wang HY; Li YQ; Meng HF; Dai F; Jin JD
    Sci Rep; 2016 Feb; 6():21420. PubMed ID: 26892992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel AMPK-PEA15 axis in the anoikis-resistant growth of mammary cells.
    Hindupur SK; Balaji SA; Saxena M; Pandey S; Sravan GS; Heda N; Kumar MV; Mukherjee G; Dey D; Rangarajan A
    Breast Cancer Res; 2014 Aug; 16(4):420. PubMed ID: 25096718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric cancer tissue-derived mesenchymal stem cells impact peripheral blood mononuclear cells via disruption of Treg/Th17 balance to promote gastric cancer progression.
    Wang M; Chen B; Sun XX; Zhao XD; Zhao YY; Sun L; Xu CG; Shen B; Su ZL; Xu WR; Zhu W
    Exp Cell Res; 2017 Dec; 361(1):19-29. PubMed ID: 28964780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomal EPHA2 derived from highly metastatic breast cancer cells promotes angiogenesis by activating the AMPK signaling pathway through Ephrin A1-EPHA2 forward signaling.
    Han B; Zhang H; Tian R; Liu H; Wang Z; Wang Z; Tian J; Cui Y; Ren S; Zuo X; Tian R; Niu R; Zhang F
    Theranostics; 2022; 12(9):4127-4146. PubMed ID: 35673569
    [No Abstract]   [Full Text] [Related]  

  • 20. Embryonic stem cell preconditioned microenvironment suppresses tumorigenic properties in breast cancer.
    He N; Feng G; Li Y; Xu Y; Xie X; Wang H; Wang Y; Ou L; Pei X; Liu N; Li Z
    Stem Cell Res Ther; 2016 Jul; 7(1):95. PubMed ID: 27460364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.